2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.
Our interviews and research unearth the visible and invisible forces contributing to healthcare's gender leadership gap.
In this episode of the Oliver Wyman Health Podcast, we share what it's like to be the only female leader in the room, and discuss how digital innovation is advancing social determinants of health.
In the wake of disruption from industries like retail and finance, healthcare incumbents must anticipate disruption from the side or above, not just head-on.
In this video, Terry Stone discusses where disruptive innovation is likely to come from and why.
According to Oliver Wyman’s Consumer Survey of US Healthcare, women are more engaged in their health decisions than men. Healthcare companies must give female consumers the kind of health system they're seeking.
In light of breaking news, the pharma value chain is definitely ripe for disruption. Here's how health plans, employers, and drug companies can adjust to the new normal.
2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.
Disruption in healthcare will be driven by the power of its trapped – and highly exploitable – value.
While the Graham-Cassidy bill failed to come to a vote keeping ACA as the law of the land, changes are coming. Here are four ways to react.